ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,307.70
-0.08%
S&P ASX All Technology
3,888.90
0.65%
Brent Oil
73.03
-0.10%
US Dollar vs AUD
1.58353
0.37%
Bitcoin
103,912.68
-2.11%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Penumbra Inc (PEN)

  7. Penumbra Inc (PEN) News

Penumbra Inc

Penumbra Inc (PEN)

Peninsula Energy Ltd
Pennant International Group Plc
PBF Energy Inc
247.55
0.31
(0.13%)
Closed 18 December 8:00AM
Delayed by 15 minutes
247.55
0.00
(0.00%)
After Hours: 11:37AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

PEN News

Official News Only

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
4 hours ago
PEN (0.13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
4 hours ago
PEN (0.13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
4 hours ago
PEN (0.13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 December 2024
PEN (0.13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 December 2024
PEN (0.13%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 December 2024
PEN (0.13%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
30 November 2024
PEN (0.13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
23 November 2024
PEN (0.13%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
21 November 2024
PEN (0.13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 November 2024
PEN (0.13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 November 2024
PEN (0.13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 November 2024
PEN (0.13%)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Edgar (US Regulatory)
13 November 2024
PEN (0.13%)

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 4 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 9 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 9 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 9 years ago
IPO should be out soon.
no symbol yet.
👍️0

Your Recent History

NYSE
PEN
Penumbra
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved